$40.00
-0.16-0.40%
At Close: -
$40.71
0.711.77%
After Hours: Sep 19, 6:31 AM EDT
15 minutes delayed
Calliditas Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Calliditas Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $-0.16 | $-0.10 | -60.0 % |
Mar 2024 | 2024-05-23 | $-0.88 | $-0.14 | -528.6 % |
Dec 2023 | 2024-02-21 | $-0.06 | $-0.07 | 8.57 % |
Sep 2023 | 2023-11-07 | $-0.58 | $-0.31 | -87.1 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $52.35M | $43.63M | 20.0 % |
Mar 2024 | 2024-05-23 | $28.43M | $34.70M | -18.1 % |
Dec 2023 | 2024-02-21 | $42.41M | $35.86M | 18.3 % |
Sep 2023 | 2023-11-07 | $27.25M | $28.59M | -4.70 % |
Calliditas Therapeutics (CALT) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.
The Actual EPS was $-0.16, which missed the estimate of $-0.10.
The Actual Revenue was $52.4M, which beat the estimate of $43.6M.
Browse earnings estimates, EPS, and revenue on all stocks.